Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious and debilitating disease caused by occlusion of the pulmonary arterial bed by hematic emboli and by the resulting fibrous material. Such occlusion increases vascular resistance and, consequently, the pressure in the region of the pulmonary artery, which is the definition of pulmonary hypertension. The increased load imposed on the right ventricle leads to its progressive dysfunction and, finally, to death. However, CTEPH has a highly significant feature that distinguishes it from other forms of pulmonary hypertension: the fact that it can be cured through treatment with pulmonary thromboendarterectomy. Therefore, the primary objective of the management of CTEPH should be the assessment of patient fitness for surgery at a referral center, given that not all patients are good candidates. For the patients who are not good candidates for pulmonary thromboendarterectomy, the viable therapeutic alternatives include pulmonary artery angioplasty and pharmacological treatment. In these recommendations, the pathophysiological bases for the onset of CTEPH, such as acute pulmonary embolism and the clinical condition of the patient, will be discussed, as will the diagnostic algorithm to be followed and the therapeutic alternatives currently available.

Atualização no Tratamento da Hipertensão Arterial Pulmonar

“…Recomendações para diagnóstico e tratamento dos pacientes com HPTEC podem ser encontradas em outras publicações. 16 O grupo V inclui pacientes com doenças mais raras, com múltiplos mecanismos. 8 As diferentes etiologias de HP e sua classificação em grupos estão descritos na Tabela 1.…”

World Pulmonary Hypertension Day: reflections and planning

“…A Comissão de Circulação Pulmonar da Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) foi fundada em 1996 por iniciativa do Professor Sérgio Saldanha Menna-Barreto e tem atuado, ao longo dos anos, na educação continuada e na elaboração de diretrizes ou recomendações no manejo da HAP (1) e hipertensão pulmonar tromboembólica crônica. (2) A atualização das recomendações no manejo da HAP está sendo programada pela comissão atual.…”